MLTX
Price
$52.08
Change
+$0.20 (+0.39%)
Updated
Dec 20, 04:59 PM (EDT)
93 days until earnings call
PGEN
Price
$0.76
Change
+$0.03 (+4.11%)
Updated
Dec 20, 04:59 PM (EDT)
67 days until earnings call
Ad is loading...

MLTX vs PGEN

Header iconMLTX vs PGEN Comparison
Open Charts MLTX vs PGENBanner chart's image
MoonLake Immunotherapeutics
Price$52.08
Change+$0.20 (+0.39%)
Volume$3.4K
CapitalizationN/A
Precigen
Price$0.76
Change+$0.03 (+4.11%)
Volume$12.59K
CapitalizationN/A
MLTX vs PGEN Comparison Chart
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. PGEN commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Hold and PGEN is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (MLTX: $52.17 vs. PGEN: $0.76)
Brand notoriety: MLTX and PGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 93% vs. PGEN: 196%
Market capitalization -- MLTX: $3.29B vs. PGEN: $223.34M
MLTX [@Biotechnology] is valued at $3.29B. PGEN’s [@Biotechnology] market capitalization is $223.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whilePGEN’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • PGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than PGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 5 TA indicator(s) are bullish while PGEN’s TA Score has 3 bullish TA indicator(s).

  • MLTX’s TA Score: 5 bullish, 4 bearish.
  • PGEN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than PGEN.

Price Growth

MLTX (@Biotechnology) experienced а +1.62% price change this week, while PGEN (@Biotechnology) price change was +12.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

MLTX is expected to report earnings on Mar 24, 2025.

PGEN is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.29B) has a higher market cap than PGEN($223M). MLTX YTD gains are higher at: -13.612 vs. PGEN (-43.090). MLTX has higher annual earnings (EBITDA): -108.45M vs. PGEN (-136.11M). MLTX has more cash in the bank: 494M vs. PGEN (28.6M). MLTX has less debt than PGEN: MLTX (3.69M) vs PGEN (5.75M). PGEN has higher revenues than MLTX: PGEN (3.96M) vs MLTX (0).
MLTXPGENMLTX / PGEN
Capitalization3.29B223M1,475%
EBITDA-108.45M-136.11M80%
Gain YTD-13.612-43.09032%
P/E RatioN/AN/A-
Revenue03.96M-
Total Cash494M28.6M1,727%
Total Debt3.69M5.75M64%
FUNDAMENTALS RATINGS
PGEN: Fundamental Ratings
PGEN
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
44

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXPGEN
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
51%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
63%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGMAX7.590.09
+1.20%
Voya Global Insights Portfolio ADV
RFNBX80.560.73
+0.91%
American Funds Fundamental Invs R2
MAFGX43.36N/A
N/A
BlackRock Capital Appreciation Instl
CVFYX15.07N/A
N/A
Pioneer Disciplined Value Y
FHEQX13.41N/A
N/A
Federated Hermes SDG Engagement Eq A

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.56%
XENE - MLTX
41%
Loosely correlated
-0.54%
EDIT - MLTX
41%
Loosely correlated
-2.24%
AXSM - MLTX
40%
Loosely correlated
+1.16%
DNLI - MLTX
39%
Loosely correlated
-0.14%
CRNX - MLTX
39%
Loosely correlated
+1.44%
More

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with CRSP. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
+5.07%
CRSP - PGEN
53%
Loosely correlated
+0.83%
NTLA - PGEN
51%
Loosely correlated
+1.08%
RCKT - PGEN
50%
Loosely correlated
+2.03%
BEAM - PGEN
50%
Loosely correlated
+8.16%
NKTX - PGEN
50%
Loosely correlated
+7.73%
More